Einloggen
Einloggen
Oder einloggen mit
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registrieren
Oder einloggen mit
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Startseite
  2. Aktien
  3. Vereinigtes Königreich
  4. London Stock Exchange
  5. GSK plc
  6. News
  7. Andere Sprachen
    GSK   GB00BN7SWP63

GSK PLC

(GSK)
  Bericht
Verzögert London Stock Exchange  -  17:35:29 06.02.2023
1461.00 GBX   +1.49%
08:18MÄRKTE EUROPA/US-chinesische Spannungen und Zinssorgen belasten
DJ
02.02.GSK plc : Erhält eine Verkaufsbewertung von JPMorgan
MM
02.02.Deutsche Bank Research belässt GSK auf 'Hold' - Ziel 1500 Pence
DP
ÜbersichtKurseChartsNewsRatingsTermineUnternehmenFinanzenAnalystenschätzungenRevisionenDerivateFonds 
ÜbersichtAlle NewsAnalystenempfehlungenAndere SprachenPressemitteilungenOffizielle PublikationenBranchen-News
Nachrichten in anderen Sprachen über GSK PLC
18:55FTSE 100 Closed Down 0.8% Amid Strong US Jobs Data
14:57Cronache di Borsa - Lunedì 6 Febbraio
13:30Gsk : announces results from 17-year retrospective study on US clinical trial diversity
03.02.Cronache di Borsa - Venerdì 3 Febbraio
03.02.Gsk: morgan stanley cuts target price to 1485p from 1520p…
02.02.GSK : le comprimé Jesduvroq approuvé dans l'anémie aux USA
02.02.GSK plc - Benlysta granted Orphan Drug Designation by US FDA for the potential treatmen..
02.02.Tranche Update on Quest Diagnostics Incorporated (N..
02.02.Gsk : FY 2022 results transcript
02.02.Jesduvroq (daprodustat) approved by US FDA for anaemia of chronic kidney disease in ad..
02.02.Benlysta granted Orphan Drug Designation by US FDA for the potential treatment of syste..
02.02.GSK gets FDA approval for drug to treat anaemia in adults on dialysis
02.02.Goldman Sachs cuts Standard Chartered
02.02.GSK's Oral Anemia Drug for Dialysis Patients Secures First-in-Class US FDA Nod
02.02.GSK plc Announces US Food and Drug Administration Approval of Jesduvroq (Daprodustat), ..
02.02.Gsk : Jesduvroq (daprodustat) approved by US FDA for anaemia of chronic kidney disease in ..
02.02.U.S. FDA approves GSK's anemia drug for patients on dialysis
02.02.U.S. FDA approves new GSK's anemia drug
02.02.Quest Diagnostics Incorporated announces an Increase in Equity Buyback
01.02.Health Care Up After GSK Earnings -- Health Care Roundup
01.02.Analysis-GSK gives few clues on plans to replenish medicine cabinet
01.02.Ionis Earns $15 Million Milestone Payment as GSK Advances Bepirovirsen to Phase 3 Studi..
01.02.FTSE 100 Closes Down 0.1% as Market Awaits Fed -2-
01.02.FTSE 100 Closes Down 0.1% as Market Awaits Fed Meeting
01.02.Global markets live: AMD, Amgen, Electronic Arts, PayPal, Snap...
01.02.GSK's Treatment Candidate for Systemic Sclerosis Gets US FDA's Orphan Drug Designation
01.02.Big pharma: GSK beats forecasts, but Novartis lags
01.02.GSK : désignation de médicament orphelin de la FDA
01.02.GSK plc Declares Fourth Interim Dividend for 2022, Payable on 13 April 2023; Provides D..
01.02.Cronache di Borsa - Mercoledì 1 Febbraio
01.02.Tesco Could Make Further Acquisitions Given -2-
01.02.Tesco Could Make Further Acquisitions Given Robust Free Cash Flow
01.02.Wall Street attend la Fed, l'Europe profite du ralentissement de l'inflation
01.02.Point marchés-Wall Street attend la Fed, l'Europe profite du ralentissement de l'inflat..
01.02.Fed Policy Announcement Eyed as Exchange-Traded Funds, Equity Futures Fall Pre-Bell Wed..
01.02.Trending : GSK 4Q Earnings, Sales Beat Expectations
01.02.European Midday Briefing: Investors Eye Fed Decision
01.02.Vodafone's Europe woes, Darktrace in trouble: Marke..
01.02.Restructuration pour Orpéa, record absolu pour Exxo..
01.02.Sterling Should Rise if BOE Lifts Rates By 50Bp, Will Fall Sharply on 25Bp Increase
01.02.GSK's Q4 Adjusted Earnings, Sales Increase; Issues 2023 Outlook
01.02.Glaxo : Q4 Earnings Snapshot
01.02.GSK: bénéfice 2022 dopé par la scission des soins grand public
01.02.Stocks to Watch in Europe: GSK, Novartis, Novo Nordisk, BBVA, ..
01.02.GSK : 4ème trimestre meilleur que prévu, confiance pour 2023
01.02.British Drugmaker GSK Upbeat on 2023 Prospects Amid Expected Vaccines Boost
01.02.GSK profit up; Vodafone growth slows; US Fed ahead
01.02.Les marchés retiennent leur souffle, la Fed sous les projecteurs
01.02.GSK profit grows as aims for first-ever approved RSV vaccine
01.02.FTSE 100 Rises as Entain, Halma Rally
01.02.GSK fait mieux que prévu au quatrième trimestre
01.02.L'optimisme de retour en Europe avant l'inflation et la Fed
01.02.GSK: bénéfice 2022 plus que triplé à 15 milliards de livres
01.02.Sterling Faces Sustained Weakness on UK Growth Concerns
01.02.L'optimisme de retour en Europe avant l'inflation et la Fed
01.02.GSK 4Q Sales and Earnings Rose, Driven by Specialty Medicines, Vaccines -- Update
01.02.Gsk : FY 2022 results slides
01.02.Gsk gagne 1,1% après la publication de ses résultats trimestriels
01.02.CORRECT: Stocks open higher ahead of US Fed rate decision
01.02.Pas de blague, hein ?
01.02.GSK boekt minder kwartaalomzet
01.02.Stocks called higher ahead of US Fed rate decision
01.02.GSK 4Q Sales and Earnings Rose, Driven by Specialty Medicines, Vaccines
01.02.CAC 40 : des prises d'initiative limitées avant la Fed
01.02.British Drugmaker GSK's FY22 Profit Tops Estimates Amid Record Shingrix Sales
01.02.US FDA Grants Orphan Drug Designation to GSK's Systemic Sclerosis Treatment
01.02.En Direct des Marchés : Airbus, Orpea, Derichebourg, Bonduelle, GS..
01.02.Gsk - gsk expects turnover and adjusted operating profit gro…
01.02.Gsk - 2023 guidance at cer and excludes any contribution fro…
01.02.Gsk - 2023 turnover expected to increase between 6% to 8%…
01.02.Gsk - 2023 adjusted operating profit expected to increase be…
01.02.Gsk plc - final results…
01.02.Gsk - 13.75p dividend declared for q4 2022. no change to exp…
01.02.Gsk- fy (not qtrly) covid-19 solutions (xevudy) sales…
01.02.GSK reports Q4 profit, sales beat Wall Street estimates
01.02.Gsk : 2022 ESG updates at a glance
01.02.Gsk : FY 2022 results infographic
01.02.GSK Says Benlysta Granted Orphan Drug Designation By FDA
01.02.GSK reports Q4 profit, sales beat Wall Street estimates
01.02.Gsk : delivers strong 2022 performance with full year sales of £29.3 billion +19% AER, +13..
01.02.Earnings Flash (GSK.L) GSK Posts FY22 Revenue GBP29.32B
01.02.Earnings Flash (GSK.L) GSK Reports FY22 EPS GBX109.2
01.02.BOLETÍN MATINAL: 1 de febrero de 2023
01.02.GSK plc Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31..
01.02.GSK plc Provides Earnings Guidance for the Full Year 2023
01.02.Point marchés-Hausse en vue en Europe avec l'espoir d'une accalmie sur les taux de la F..
01.02.Stocks called up as all eyes on Fed decision
01.02.Marketmind: Lights, camera, action
01.02.EMEA Morning Briefing: Stocks Poised for a Mixed Start Ahead of Fed Decision
01.02.Les valeurs à suivre à Paris et en Europe (actualisé)
31.01.Haleon to Weigh Large Potential Deals to Expand Its Brand Portfolio
31.01.FTSE 100 Closes Down 0.17% Dragged by Miners, Oil Stocks
31.01.Global markets live: GM, Pfizer, Exxon, UBS, Boeing...
31.01.Unilever turns to former Heinz exec to steer new course
31.01.Pre-Fed nerves and IMF outlook weigh on stocks
31.01.Haleon appoints Pfizer Chief Financial Officer David Denton to board
31.01.UK Green Gilt Issuance Will Be Limited in Coming Years
31.01.UK Consumers' Lower Borrowing at Year-End Signals Hit to Economy
31.01.FTSE 100 Falls as IMF Highlights UK's Economic Fragility
31.01.Unilever turns to former Heinz exec to steer new course
Anstehende Termine für GSK PLC